MedTrace Logo

Effect of Konjac-mannan in Individuals With Insulin-Resistance Syndrome

NCT03741686 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2018-11-15

No results posted yet for this study

Summary

To study whether a diet high in fiber from Konjac-mannan (KJM) has an effect on metabolic control in individuals with insulin resistance syndrome.

Conditions

  • Insulin Resistance Syndrome

Interventions

DIETARY_SUPPLEMENT

konjac glucomannan

Konjac-mannan fiber-enriched biscuits (0.5 g/412KJ \[100kcal\] of glucommanan)

DIETARY_SUPPLEMENT

wheat bran

Wheat bran (hard red wheat bran) fiber enriched biscuits

Sponsors & Collaborators

  • Dicofarm

    collaborator OTHER

  • University of Toronto, Toronto

    collaborator UNKNOWN

  • Unity Health Toronto

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1991-01-31
Primary Completion
1992-06-30
Completion
1999-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03741686 on ClinicalTrials.gov